Atlas Trials

Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab

Clinical trial NCT01125787 · TERMINATED

Trial details

NCT number
NCT01125787
Sponsor
Nevada Cancer Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia (CLL)
Start date
2010-05-01
Primary completion
2010-08-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.